AMD ($4.30) set a multiyear high at $4.30 on Tuesday and has been above its 200-day simple moving average at $3.65 since Nov. 27. The weekly chart profile is positive with its five-week MMA at $3.90 and 200-week SMA at $5.70. AMD has a buy rating, is 22.4% undervalued and has gained 62.9% over the last 12 months. My weekly value level is $4.09, with a monthly risky level at $4.66. My quarterly value level is $2.98 with a semiannual risky level at $8.05.

Broadcom (BRCM) ($29.41) has been above its 50-day SMA at $27.81 since Dec. 2, with its 200-day SMA at $30.03. The weekly chart profile is positive but overbought with its five-week MMA at $28.44 and its 200-week SMA at $34.39. Broadcom has a buy rating, is 2.3% undervalued and has lost 15.1% over the last 12 months. My monthly value level is $22.06 with a weekly pivot at $29.22 and annual risky level at $32.12.

Cree ($63.25) has been trading back and forth around its 200-day SMA at $61.46 since Nov. 7. The weekly chart profile is positive with its five-week MMA at $61.76 and its 200-week SMA at $45.94. Cree has a hold rating and is 31.7% overvalued with a gain of 98.8% over the last 12 months. My annual value level is $55.64 with weekly, semiannual and monthly risky levels at $63.87, $64.80 and $66.39.

Intel ($26.51) set a multiyear intraday high at $26.55 on Tuesday and has been above its 200-day SMA since Oct. 10 with this average now at $23.72. The weekly chart profile is positive but overbought with its five-week MMA at $25.26 and its 200-week SMA at $22.85. Intel has been downgraded to hold from buy and is 26.6% overvalued with a gain of 20.5% over the last 12 months. Weekly, quarterly and monthly value levels are $25.33, $24.40 and $24.26, with a semiannual pivot at $26.33 and semiannual risky level at $28.95.

KLA-Tencor($63.86) set a multiyear intraday high at $67.05 on Oct. 29 with its 200-day SMA at $58.98. The weekly chart profile shifts to negative given a close this week below its five-week MMA at $63.34 with its 200-week SMA at $46.59. KLA has a buy rating, is 41.1% overvalued and has gained 30.5% over the last 12 months. Quarterly and semiannual value levels are $62.28 and $60.93 with semiannual and monthly risky levels at $65.55 and $66.87.

LAM Research (LRCX)($55.89) set a multiyear intraday high at $56 on Tuesday, with its 200-day SMA at $49.18. The weekly chart profile is positive, with its five-week MMA at $53.80 and its 200-week SMA at $43.15. LAM has a hold rating, is 23.7% overvalued and has gained 46.2% over the last 12 months. Monthly and annual value levels are $54.55, $53.18 and $50.58 with a semiannual risky level at $59.11.

Marvell Tech (MRVL) ($15.81) set a 52-week intraday high at $15.82 on Tuesday with its 200-day SMA at $12.16. The weekly chart profile is positive but overbought, with its five-week MMA at $14.24 and its 200-week SMA at $14.06. Marvel has a hold rating, is 20.2% overvalued and has gained 80.9% over the last 12 months. Monthly and annual value levels are $14.60 and $13.97, with a semiannual risky level at $16.87.

If you liked this article you might like

7 Essential Rules for Investing in Tech Stocks

Wall Street Deflates in Pullback After Fed Excitement, No Records for Dow

Your Guide to Making a Lot of Money on the Driverless Car Boom